Atlas Venture
http://www.atlasventure.com/Atlas Venture is a venture capital firm that invests in early stage technology and life sciences businesses. Since the firm’s founding in 1980, the firm has helped build over three hundred companies. Since 1995, forty seven of its investments have been acquired and more than forty have gone public, with an aggregate market capitalization of over $20 billion.
View Older Stories View More Recent Stories
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Dyne Therapeutics adds Brian Posner to board of directors
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
-
Form 144 Sionna Therapeutics, Filed by: Atlas Venture Opportunity Fund II, L.P.
-
Hengrui Pharma licenses cardiac drug to Braveheart Bio for $75 million upfront
-
Form D Atlas Venture Opportunit
-
Form N-PX Atlas Venture Life Scien For: Jun 30
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form SCHEDULE 13D/A Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 13F-HR Atlas Venture Life Scien For: Jun 30
-
Form SCHEDULE 13D/A Vigil Neuroscience, Inc. Filed by: Atlas Venture Fund XII, L.P.
-
Form 4 Vigil Neuroscience, Inc. For: Aug 05 Filed by: Atlas Venture Fund XII, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form SCHEDULE 13D/A ImageneBio, Inc. Filed by: Atlas Venture Fund X, L.P.
-
Form 13F-NT Atlas Venture Associates For: Jun 30
-
Form 13F-NT Atlas Venture Associates For: Jun 30
-
Form 13F-NT Atlas Venture Fund VIII, For: Jun 30
-
Form 13F-HR Atlas Venture Advisors, For: Jun 30
-
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.

